Read our earnings report guide before you consider the forecast information when making investment decisions. Visit the Earnings Calendar to see dates for upcoming earnings announcements.

Celestica (CLS) is one of the stocks most watched by ... we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the ...

Celestica Inc. CLS has lost 10.8% over the past ... Non-GAAP adjusted effective tax rate is forecasted to be approximately 19 ...

Celestica (CLS) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). This rating change essentially reflects an upward trend in earnings estimates -- one ...

But I wouldn't call it a disaster for CLS's business model. Assuming that we'll see no earnings beat for FY2025 and the firm reports in line with the current EPS consensus of $4.83, and also ...

Don't miss insights, networking & opportunities this fall. CLS Holdings USA, Inc. (OTCQB: CLSH) (CSE: CLSH) cannabis company operating as Cannabis Life Sciences announced its first quarter ...

Its pipeline includes CLS-AX, an Integrin Inhibitor, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in ...

Celestica (CLS) has been one of the most searched-for stocks on ... Rather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is ...